中國國家文化產業(00745.HK)擬折讓9.38%配售1.18億股 籌資1670萬港元
格隆匯4月8日丨中國國家文化產業(00745.HK)公吿,於2021年4月8日,公司與配售代理訂立配售協議,公司擬配售最多1.18億股,相當於已發行股本約20.00%及經發行配售股份擴大後已發行股本約16.67%。配售價每股配售股份0.145港元,較於配售協議日期收市價每股股份0.16港元折讓約9.38%。
配售事項估計所得款項淨額約1670萬港元。公司擬將有關所得款項淨額用作發展集團的電影分部,包括但不限於投資、購買及發行電影、網絡連續劇和電視劇內容。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.